| Dr Michael Ervin Miner, MD | |
|
4500 S Lancaster Rd, Dallas, TX 75216-7167 | |
| (214) 857-1811 | |
| Not Available |
| Full Name | Dr Michael Ervin Miner |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 4500 S Lancaster Rd, Dallas, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700963238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 35.058566 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Ervin Miner, MD 2 Ascot Dr, Duncanville, TX 75116-2033 Ph: (614) 327-3463 | Dr Michael Ervin Miner, MD 4500 S Lancaster Rd, Dallas, TX 75216-7167 Ph: (214) 857-1811 |
News Archive
CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has initiated a pivotal global Phase 3 clinical trial to evaluate the efficacy and safety of aldoxorubicin as a second-line treatment for patients with soft tissue sarcoma (STS) under a Special Protocol Assessment with the FDA.
Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced it treated its first patients in a phase I study of Debio 1143 combined with Carboplatin and Paclitaxel in patients with squamous non-small cell lung cancer, platinum-refractory ovarian cancer, and basal-like/claudin low triple negative breast cancer.
Researchers at Fox Chase Cancer Center have made a crucial discovery that may help physicians better diagnose and treat children with Hirschsprung disease, a debilitating and sometimes life-threatening ailment that causes bowel obstruction and involves an array of genetic changes.
At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.
Results from an international study presented today at the International Liver Congress have shown Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC.
› Verified 5 days ago
Matthew Sun, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-9946 | |
Dr. Martin Lewis Lazar, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 7777 Forest Ln, Suite B420, Dallas, TX 75230 Phone: 972-566-6444 Fax: 972-566-6627 | |
Dr. Blake Arden Yarascavitch, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1935 Medical District Dr, Suite B-3200, Dallas, TX 75235 Phone: 214-456-6660 | |
Kalil G Abdullah, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5303 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2300 Fax: 214-648-2204 | |
James Ebot, DO Neurological Surgery Medicare: Medicare Enrolled Practice Location: 17218 Preston Rd Ste 2000, Dallas, TX 75252 Phone: 877-866-7123 | |
Dr. Charles Benjamin Newman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 N Beckley Ave, Pav Iii Ste#152, Dallas, TX 75203 Phone: 214-948-2076 Fax: 214-948-9990 | |
Bruce Edward Mickey, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2300 Fax: 214-645-2301 |